Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose: Gasdermin B (GSDMB) overexpression/amplification occurs in about 60% of HER2 breast cancers, where it promotes cell migration, resistance to anti-HER2 therapies, and poor clinical outcome. Thus, we tackle GSDMB cytoplasmic overexpression as a new therapeutic target in HER2 breast cancers. Experimental Design: We have developed a new targeted nanomedicine based on hyaluronic acid–biocompatible nanocapsules, which allow the intracellular delivery of a specific anti-GSDMB antibody into HER2 breast cancer cells both in vitro and in vivo. Results: Using different models of HER2 breast cancer cells, we show that anti-GSDMB antibody loaded to nanocapsules has significant and specific effects on GSDMB-overexpressing cancer cells' behavior in ways such as (i) lowering the in vitro cell migration induced by GSDMB; (ii) enhancing the sensitivity to trastuzumab; (iii) reducing tumor growth by increasing apoptotic rate in orthotopic breast cancer xenografts; and (iv) diminishing lung metastasis in MDA-MB-231-HER2 cells in vivo. Moreover, at a mechanistic level, we have shown that AbGB increases GSDMB binding to sulfatides and consequently decreases migratory cell behavior and may upregulate the potential intrinsic procell death activity of GSDMB. Conclusions: Our findings portray the first evidence of the effectiveness and specificity of an antibody-based nanomedicine that targets an intracellular oncoprotein. We have proved that intracellular-delivered anti-GSDMB reduces diverse protumor GSDMB functions (migration, metastasis, and resistance to therapy) in an efficient and specific way, thus providing a new targeted therapeutic strategy in aggressive HER2 cancers with poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088 · cited 3×
“After specific stimuli (such as viruses, bacterial infections, or chemotherapeutic agents), the gasdermin N-terminus domain binds to certain lipids in the plasma membrane and organella (lysosomes, mitochondria), for instance phosphoinositides or cardiolipin (13, 14, 32).”
BackgroundResultPore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771 · cited 3×
“In this case, GSDMBwouldwork in the sameway asmutantGsdma3 does, which can promote cell death independently of cleavage (19, 41, 42).”
BackgroundRogers, C., Fernandes-Alnemri, T., Mayes, L., Alnemri, D., Cingolani, G., & Alnemri, E. S. (2017) · Nature Communications · doi:10.1038/ncomms14128 · Cited by 1,510
Stability of Self-Assembled Polymeric Micelles in Serum
Lu, J., Owen, S. C., & Shoichet, M. S. (2011) · Macromolecules · doi:10.1021/ma200675w · Cited by 299 · cited 1×
“S3C), according to established protocols (28).”
‘Hints’ in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death
Qiu, S., Liu, J., & Xing, F. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.24 · Cited by 111 · cited 10×
“org Clin Cancer Res; 25(15) August 1, 2019 4853”
BackgroundInfluential
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Channelling inflammation: gasdermins in physiology and disease
Liu, X., Xia, S., Zhang, Z., Wu, H., & Lieberman, J. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00154-z · Cited by 751
Pyroptosis, metabolism, and tumor immune microenvironment
Du, T., Gao, J., Li, P., Wang, Y., Qi, Q., Liu, X., Li, J., Wang, C., & Du, L. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.492 · Cited by 324
Zhang, S., Sun, Q., Peng, X., Gan, N., Zhao, L., Suo, Z., Zhao, G., & Li, H. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01619a · Cited by 16
Metadata
- Authors
- Molina-Crespo, Á., Cadete, A., Sarrio, D., Gámez-Chiachio, M., Martinez, L., Chao, K., Olivera, A., Gonella, A., Díaz, E., Palacios, J., Dhal, P. K., Besev, M., Rodríguez-Serrano, M., García Bermejo, M. L., Triviño, J. C., Cano, A., García-Fuentes, M., Herzberg, O., Torres, D., Alonso, M. J., & Moreno-Bueno, G.
- Venue
- Clinical Cancer Research
- Published
- 2019-08-01
- Volume
- 25
- Issue
- 15
- Pages
- 4846-4858
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2943983202
- Cited by
- 118
- References
- 5
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-2381
- The paper
- Molina-Crespo, Á., Cadete, A., Sarrio, D., Gámez-Chiachio, M., Martinez, L., Chao, K., Olivera, A., Gonella, A., Díaz, E., Palacios, J., Dhal, P. K., Besev, M., Rodríguez-Serrano, M., García Bermejo, M. L., Triviño, J. C., Cano, A., García-Fuentes, M., Herzberg, O., Torres, D., . . . Moreno-Bueno, G. (2019). Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-2381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.